Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Interim Management Statement

4 Jul 2008 16:15

RNS Number : 3949Y
Aberdeen Income & Growth VCT PLC
04 July 2008
Β 

ο»Ώ

AberdeenΒ Income and GrowthΒ VCT PLCΒ ("the Company")

Interim Management StatementΒ -Β Quarter ended 31 MayΒ 2008

ThisΒ Interim Management Statement,Β for theΒ quarterΒ endedΒ 31Β MayΒ 2008, is provided in accordance with Rule 4.3 of the Disclosure and TransparencyΒ Rules of the UK Listing AuthorityΒ andΒ also includes relevant informationΒ in respect of the period from 1Β JuneΒ 2008Β toΒ the date ofΒ issue.Β ThisΒ Statement has been prepared solely to provide additional informationΒ in orderΒ to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders,Β or any other party,Β for any other purpose.

FinancialΒ highlights

Net Asset Value* ("NAV") ofΒ 73.2pΒ per shareΒ atΒ 31 May 2008Β compared to 72.8p per share atΒ 29 February 2008.

Β 

FinalΒ dividendΒ ofΒ 2.3p per shareΒ to beΒ paidΒ onΒ 25Β JulyΒ 2008, bringing total dividend payment for the year ended 29 February 2008 to 5.8p, equivalent to a yield of 7.7% from an equity investment to a higher-rate taxpayer who subscribed at launch and, if the initial tax relief of 20% is taken into account, the effective annual yield rises to 9.7%. On the current mid-market price ofΒ 40.5p, the equivalent yield from an equity investment to a higher-rate taxpayer would beΒ 19.1%.

Β 

*The NAVΒ is unaudited andΒ reflects theΒ closingΒ bid priceΒ of quoted securitiesΒ atΒ 31Β MayΒ 2008. Unlisted companies areΒ normallyΒ valued on a six-monthly basis and the NAV incorporates the Directors'Β valuationΒ of unlistedΒ investmentsΒ asΒ atΒ 29 February 2008.Β 

InvestmentsΒ and Disposals

Β 

During the quarter endedΒ 31Β MayΒ 2008,Β investmentsΒ totallingΒ Β£1,008,000 were madeΒ inΒ threeΒ unlistedΒ and twoΒ AIM quoted companies.

Β 

DuringΒ theΒ same period, a combination of partial and complete disposals ofΒ sevenΒ AIM quoted investments generated aggregate proceeds of Β£257,000 against cost of Β£350,000 and included the sale of the holding in Citel Technologies where a loss of Β£165,000 was realised; however, the fall in the value of this investment had previously been recognised and there was no resulting impact on the Company's NAV. In addition,Β aΒ combination of partial and complete disposalsΒ ofΒ fiveΒ unlisted investments generated proceeds of Β£1,887,000 against cost of Β£1,283,000 with theΒ gain arising from the sale of PSCA InternationalΒ and having previously recognised in the NAV.

Β 

There were no other material transactions during the period under review.Β 

RecentΒ developmentsΒ 

Β 

BetweenΒ 31 May 2008Β and the date of this statement,Β investmentsΒ totallingΒ Β£798,000Β were made inΒ threeΒ unlistedΒ companiesΒ andΒ oneΒ AIM quotedΒ company.

Β 

DuringΒ the same post quarter-end period,Β disposalsΒ ofΒ oneΒ unlistedΒ investmentΒ andΒ eightΒ AIM quoted investmentsΒ generatedΒ aggregateΒ proceeds of Β£1,556,000Β against cost of Β£1,832,000. TheseΒ included theΒ disposal of a number of AIM quoted holdingsΒ where there was deemed to be little chance of a recovery in value andΒ whereΒ an aggregate realisedΒ ofΒ loss Β£776,000 had previously been recognised. Therefore,Β there wasΒ no resulting impact on the Company's NAVΒ and certain of these holdingsΒ were exchanged forΒ new sharesΒ inΒ an independent close-ended investment company that has been established to acquire quoted securities from financial institutions.Β Also includedΒ in the post quarter end disposals,Β was the sale of the unlisted investment in IΒ D Support Services Holdings whichΒ generated proceeds of Β£1,234,000Β against cost of Β£746,000Β and an investment of Β£89,000 in a new company, which is included in the figure quoted above, with the gain already having been recognised.

Other than described aboveΒ and changes inΒ theΒ value of investments quoted on regulated markets,Β theΒ Board is not aware of anyΒ material events during the period from 1Β MarchΒ toΒ 31Β MayΒ 2008,Β or in theΒ period from 1Β JuneΒ 2008Β to the date of this announcement, which would haveΒ hadΒ a material impact on the financial position of the Company.

Issued on behalf of the Board

Aberdeen Asset ManagementΒ PLC, Secretary

4Β July 2008

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSUUUBUMUPRGAC
Date   Source Headline
28th Jan 202511:25 amRNSDirector/PDMR Shareholding
28th Jan 202510:39 amRNSIssue of Equity
24th Jan 202511:32 amRNSNet Asset Value(s)
29th Nov 20249:33 amRNSIssue of Equity - Dividend Investment Scheme
26th Nov 20243:51 pmRNSStatement re Dividend Investment Scheme
14th Nov 20242:51 pmRNSResult of General Meeting
24th Oct 20247:00 amRNSHalf-year Report
17th Oct 20244:27 pmRNSTransaction in Own Shares
16th Oct 20244:59 pmRNSTransaction in Own Shares
14th Oct 20243:25 pmRNSUnaudited Net Asset Value and Interim Dividend
27th Sep 20244:31 pmRNSPublication of a Prospectus
5th Sep 20244:45 pmRNSUnaudited Net Asset Value
19th Jul 20242:25 pmRNSIssue of Equity - Dividend Investment Scheme
18th Jul 20244:16 pmRNSTransaction in Own Shares
17th Jul 20245:03 pmRNSTransaction in Own Shares
15th Jul 20243:07 pmRNSStatement re Dividend Investment Scheme
15th Jul 20242:23 pmRNSStatement re Dividend Investment Scheme
12th Jul 20242:56 pmRNSNet Asset Value(s)
11th Jul 20241:38 pmRNSResult of AGM
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
31st May 20244:16 pmRNSFinal Results
16th May 20243:13 pmRNSTransaction in Own Shares
1st May 202410:02 amRNSIssue of Equity
26th Apr 20241:33 pmRNSUnaudited NAV & Proposed Final Dividend
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:47 pmRNSIssue of Equity
27th Mar 202410:34 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
21st Mar 20243:55 pmRNSStatement re Offer for Subscription
20th Mar 20243:44 pmRNSUnaudited Net Asset Value
8th Feb 202410:27 amRNSDirector/PDMR Shareholding
8th Feb 202410:26 amRNSDirector/PDMR Shareholding
8th Feb 202410:08 amRNSIssue of Equity
30th Jan 20245:09 pmRNSTransaction in Own Shares
17th Jan 20249:59 amRNSDirector/PDMR Shareholding
17th Jan 20249:57 amRNSIssue of Equity
15th Jan 20244:25 pmRNSUnaudited Net Value Asset
1st Dec 20239:39 amRNSIssue of Equity
24th Nov 202312:04 pmRNSStatement re Dividend Investment Scheme
9th Nov 20233:35 pmRNSResult of General Meeting
19th Oct 20234:51 pmRNSTransaction in Own Shares
18th Oct 20233:54 pmRNSHalf-year Report
13th Oct 20234:56 pmRNSPublication of a Prospectus
5th Oct 20234:39 pmRNSNet Asset Value and Interim Dividend
20th Jul 20234:32 pmRNSTransaction in Own Shares
14th Jul 20239:26 amRNSIssue of Equity
7th Jul 20234:17 pmRNSStatement re Dividend Investment Scheme
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
6th Jul 20233:37 pmRNSNet Asset Value
6th Jul 20231:06 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.